Analysis of KIT mutations and c-KIT expression in Chinese Uyghur and Han patients with melanoma.

about

Differential expression of microRNAs in the normal skin of the Han and Uyghur populations in Xinjiang Province.Aberrations and clinical significance of BRAF in malignant melanoma: A series of 60 cases in Chinese Uyghur.

P2860

Q50003166-0B2BAAC7-2CDF-46A5-B782-3D8CC58A25F5 Q54096030-CBED898D-6720-47B6-BB72-4DCC56A38C81

P2860

Analysis of KIT mutations and c-KIT expression in Chinese Uyghur and Han patients with melanoma.

Item

http://www.wikidata.org/entity/Q44037924

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Analysis of KIT mutations and ...... nd Han patients with melanoma.

@en

Analysis of KIT mutations and ...... nd Han patients with melanoma.

@nl

type

Item

label

Analysis of KIT mutations and ...... nd Han patients with melanoma.

@en

Analysis of KIT mutations and ...... nd Han patients with melanoma.

@nl

prefLabel

Analysis of KIT mutations and ...... nd Han patients with melanoma.

@en

Analysis of KIT mutations and ...... nd Han patients with melanoma.

@nl

P1476

Analysis of KIT mutations and ...... nd Han patients with melanoma.

@en

P2093

D Luo

http://www.w3.org/2001/XMLSchema#string

D-Y Ren

http://www.w3.org/2001/XMLSchema#string

J-Q Liang

http://www.w3.org/2001/XMLSchema#string

S-R Yu

http://www.w3.org/2001/XMLSchema#string

W-J Chen

http://www.w3.org/2001/XMLSchema#string

W-X Liu

http://www.w3.org/2001/XMLSchema#string

X-H Shi

http://www.w3.org/2001/XMLSchema#string

X-J Kang

http://www.w3.org/2001/XMLSchema#string

X-J Wu

http://www.w3.org/2001/XMLSchema#string

X-M Pu

http://www.w3.org/2001/XMLSchema#string

P2860

L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.

Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.

Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin

Determinants of BRAF mutations in primary melanomas

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases.

Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type

Somatic activation of KIT in distinct subtypes of melanoma.

Driver mutations in melanoma: lessons learned from bench-to-bedside studies

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

P304

81-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CED.12659

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25917463

http://www.w3.org/2001/XMLSchema#string

Analysis of KIT mutations and c-KIT expression in Chinese Uyghur and Han patients with melanoma.

about

P2860

P2860

Analysis of KIT mutations and c-KIT expression in Chinese Uyghur and Han patients with melanoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698